SCHEMBL12515596

SCHEMBL12515596

O=C1OOCc2ccc(Br)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAOA P21397 3/20 0.44
MAOB P27338 3/20 0.44
PARP10 Q53GL7 2/20 0.42
PARP1 P09874 1/20 0.42
S100A4 P26447 1/20 0.41
PTPRC P08575 1/20 0.40
METAP1 P53582 1/20 0.40
TDP2 O95551 1/20 0.39
APP P05067 2/20 0.37
CMA1 P23946 1/20 0.37
AHR P35869 1/20 0.37
CHEK2 O96017 1/20 0.37
ROS1 P08922 1/20 0.37
MARK3 P27448 1/20 0.37
LTK P29376 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
MINK1 Q8N4C8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29440632 0.81 MAOA (0.62) TDP1L3MBTL1MAOAMAOBPARP10
SCHEMBL854664 0.81 MAOA (0.62) TDP1L3MBTL1MAOAMAOBPARP10
SCHEMBL18059464 0.75 KCNJ1 (0.38) TDP1MAOAMAOB
SCHEMBL7107624 0.74 MAOA (0.61) TDP1MAOAMAOBPARP10PARP1
SCHEMBL11816254 0.72 AHR (0.43) TDP1L3MBTL1PARP10PARP1METAP1
SCHEMBL3174866 0.72 PARP10 (0.43) TDP1L3MBTL1MAOAMAOBPARP10
SCHEMBL1399984 0.70 TDP1 (0.46) TDP1L3MBTL1MAOAMAOBPARP10
SCHEMBL17398790 0.70 TDP1 (0.54) TDP1L3MBTL1MAOAMAOBPARP10
SCHEMBL29738039 0.70 TDP1 (0.46) TDP1L3MBTL1MAOAMAOBPARP10
SCHEMBL13742626 0.69 ALOX15 (0.34) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110175521-A1 ORGANIC ELECTROLUMESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110175521-A1 ORGANIC ELECTROLUMESCENCE DEVICE SCO2, CHRM1, CHRM4 TDP1 2598/4885L3MBTL1 539/4885MAOA 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.